Head-to-head comparisons of preparations of interferon beta and glatiramer acetate: a series of quasi-randomised MSBase trials

T. Kalincik, M. Trojano, G. Izquierdo, P. Duquette, M. Girard, P. Grammond, A. Lugaresi, C. Oreja-Guevara, F. Grand'Maison, G. Giuliani, R. Hupperts, V. Van Pesch, R. Bergamaschi, C. Boz, R. Fernandez-Bolanos, G. Iuliano, S. Flechter, D. La Spitaleri, T. Petersen, C. EdgardoM. E. Rio, M. P. Amato, F. Verheul, J. Lechner-Scott, J. A. Cabrera-Gomez, M. Fiol, M. L. Saladino, F. Moore, N. Deri, M. Barnett, N. Vella, C. Shaw, M. Slee, A. Savino, V. Jokubaitis, H. Butzkueven, MSBase Study Group

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Pages (from-to)569-571
Number of pages3
JournalMultiple Sclerosis
Volume19
Issue numberSuppl. 11
DOIs
Publication statusPublished - Oct 2013

Keywords

  • interferon β
  • glatiramer acetate
  • disease

Cite this